The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConviviality Retail Regulatory News (CVR)

  • There is currently no data for CVR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Update

14 Mar 2018 09:55

RNS Number : 6962H
Conviviality PLC
14 March 2018
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

14 March 2018

 

Conviviality Plc

 

("Conviviality", the "Company" or the "Group")

 

Further Update

 

Further to the announcements made by Conviviality Plc on 8 March 2018 and 13 March 2018, the Company yesterday identified a payment due to HM Revenue & Customs of approximately £30.0 million which falls due for payment on 29 March 2018 and which has not been accrued for within its short term cash flow projections. This has created a short term funding requirement. The Company's announcement on 13 March 2018 confirmed an expected range of adjusted EBITDA of between £55.3 million and £56.4 million. To the extent that the current situation creates operational difficulties, this may negatively impact the adjusted EBITDA range.

 

The Company is currently in compliance with its banking covenants. The next covenant test date is 29 April 2018. The Company is subject to two banking covenants (i) for covenant debt (which excludes any amount drawn down under the Company's invoice discounting facility) to be less than 2.5 times the last 12 months adjusted EBITDA, and (ii) adjusted EBITDA to be at least 4 times the net financial charge. The Company is fully drawn under its term loans and revolving credit facility and covenant net debt at 29 April 2018 is expected to be approximately £113.0 million (which excludes any amount drawn down under the Company's invoice discounting facility). Based on the expected adjusted EBITDA of between £55.3 million and £56.4 million, this would give rise to a covenant test result of 2.04x to 2.00x adjusted EBITDA. The Company continues to expect net debt to be approximately £150.0 million for the period ending 29 April 2018 including the invoice discounting facility.

 

The Company has engaged PwC to assist it in its forthcoming discussions with HM Revenue & Customs and its key stakeholders including its lending banks, credit insurers, suppliers and other creditors, as well as to determine the potential impact of any resulting funding requirement on the Company's adjusted EBITDA expectation and compliance with its banking covenants. Following preliminary advice received from PwC, whilst there can be no guarantee, the Board believes this short term funding requirement will be satisfactorily resolved.

 

A further update will be made in due course

 

Temporary Suspension of Trading on AIM

Whilst the Board considers the anticipated impact of the above on the Company's funding position, the Company has applied for suspension of trading in the Company's ordinary shares on AIM with effect from 7:40 a.m. today.

 

Enquiries:

Investec (Nominated Adviser and Broker)

Tel: 020 7597 5970

Garry Levin / David Flin / Daniel Adams

FTI Consulting

Tel: 020 3727 1000

Jonathan Brill / Georgina Goodhew / Fiona Walker

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDJIMLTMBABMJP
Date   Source Headline
2nd Aug 20178:55 amRNSBlock Listing Update
28th Jul 20172:53 pmRNSHolding(s) in Company
28th Jul 201710:58 amRNSHolding(s) in Company
26th Jul 201710:21 amRNSHolding(s) in Company
20th Jul 201710:39 amRNSPDMR AND/OR INSIDER DEALING NOTIFICATION
17th Jul 20177:00 amRNSFinal Results for the Year Ended 30 April 2017
16th Jun 20177:00 amRNSAppointment of Sole Broker
1st Jun 20177:00 amRNSBlock Listing Update
1st Jun 20177:00 amRNSTotal Voting Rights
25th May 20177:00 amRNSTrading Update
24th May 20175:32 pmRNSHolding(s) in Company
19th May 201712:05 pmRNSNotification of Major Interest in Shares
2nd May 201710:34 amRNSTotal Voting Rights
26th Apr 20173:11 pmRNSHolding(s) in Company
24th Apr 20173:05 pmRNSHolding(s) in Company
3rd Apr 20177:00 amRNSTotal Voting Rights
29th Mar 201710:18 amRNSIssue of Equity
27th Mar 20177:00 amRNSDirector Declaration
22nd Mar 20177:00 amRNSBoard Change
21st Mar 201712:16 pmRNSHolding(s) in Company
9th Mar 201711:51 amRNSHolding(s) in Company
10th Feb 20174:31 pmRNSHolding(s) in Company
9th Feb 20172:49 pmRNSDealings Notification
8th Feb 20174:12 pmRNSHolding(s) in Company
8th Feb 20174:10 pmRNSHolding(s) in Company
8th Feb 20171:16 pmRNSHolding(s) in Company
3rd Feb 20173:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20178:59 amRNSBlock listing application
3rd Feb 20178:57 amRNSIssue of Equity
1st Feb 201712:50 pmRNSBlock Listing Update
31st Jan 20177:00 amRNSCORRECTION; HALF YEAR RESULTS
30th Jan 20177:00 amRNSHALF YEAR RESULTS
27th Jan 20173:54 pmRNSHolding(s) in Company
3rd Jan 201711:06 amRNSTotal Voting Rights
9th Dec 20163:57 pmRNSHolding(s) in Company
2nd Dec 201611:28 amRNSHolding(s) in Company
1st Dec 20162:46 pmRNSBlock Listing Application
9th Nov 20168:33 amRNSExercise of Options
1st Nov 20167:00 amRNSTrading Update
31st Oct 20164:19 pmRNSTotal Voting Rights
31st Oct 20164:11 pmRNSIssue of Equity
28th Oct 20167:00 amRNSSupply Agreement with Palmer and Harvey
29th Sep 20167:00 amRNSGrant of Awards under LTIP
28th Sep 201612:40 pmRNSIssue of Equity
16th Sep 20169:36 amRNSDirector/PDMR Shareholding
12th Sep 20162:03 pmRNSIssue of Equity and Grant of Options
12th Sep 20161:45 pmRNSResult of AGM
8th Sep 20167:00 amRNSDirector/PDMR Shareholding
18th Aug 201611:20 amRNSPosting of Annual Report and Notice of AGM
1st Aug 20167:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.